Results 181 to 190 of about 16,738 (270)
Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa +5 more
wiley +1 more source
Familial restrictive cardiomyopathy: A novel troponin mutation
M. Subramanian, H. Ahamed, N. Mathew
doaj +1 more source
Aborted sudden cardiac event in pediatric restrictive cardiomyopathy: When ST changes on ambulatory monitoring matter. [PDF]
Christmas A +5 more
europepmc +1 more source
ABSTRACT Aim The objective of this study was to investigate the global profile of plasmatic proteins of individuals affected simultaneously or not by type 2 diabetes mellitus (T2DM, well/poorly‐controlled), Dyslipidemia (DL), and Periodontitis (P). Methods Besides periodontal examination, plasma was collected for glycemic, and lipid analyses from 150 ...
François Isnaldo Dias Caldeira +7 more
wiley +1 more source
Prognostic implications of multiple chamber longitudinal strains and myocardial work in restrictive cardiomyopathy. [PDF]
Li X +11 more
europepmc +1 more source
ABSTRACT Background Permanent pacemaker (PPM) implantation is recommended in patients with sinus node dysfunction (SND). In patients with coexisting heart failure with preserved ejection fraction (HFpEF), clinicians may be hesitant to treat SND due to concerns about exacerbating heart failure.
Nicole Habel +4 more
wiley +1 more source
cTnIR193H restrictive cardiomyopathy mice satisfy high-energy metabolic demands through regulating glucose metabolism. [PDF]
Luo M +5 more
europepmc +1 more source
Utilization and Prognosis of Cardiac Device Implantation in AL Versus ATTR Amyloidosis
ABSTRACT Introduction Cardiac amyloidosis can cause congestive heart failure, arrhythmias, and heart blocks, which frequently require cardiac device implantation (CDI). However, the differences between light chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis CDI requirements are unknown. Methods A retrospective analysis was conducted using the
Bilal Hussain +7 more
wiley +1 more source

